BTG Pactual Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$7.11M	–	47
2022 Q3	$7.11M	Buy	+100,000	New	+$7.25M	1.86%	16
2022 Q2	–	Sell	-13,400	Closed	-$979K	–	118
2022 Q1	$979K	Buy	+13,400	New	+$900K	0.13%	101
2020 Q1	–	Sell	-85,000	Closed	-$5.42M	–	113
2019 Q4	$5.42M	Sell	85,000 -65,000	-43%	-$3.72M	0.89%	18
2019 Q3	$7.61M	Buy	+150,000	New	+$7.05M	3.39%	11

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BTG Pactual Global Asset Management's BMY Position: Q3 2014 in Review

BTG Pactual Global Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2014, closing a stake of 48,250 shares — an estimated $2.34M sold.

BTG Pactual Global Asset Management first reported a position in BMY in Q4 2013 and held it in 3 quarters. The position peaked at $2.34M in Q2 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

BTG Pactual Global Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2014 after selling out during the quarter.
BTG Pactual Global Asset Management sold 48,250 Bristol-Myers Squibb shares in Q3 2014, an estimated $2.34M.
BTG Pactual Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 3 quarters.
BTG Pactual Global Asset Management's Bristol-Myers Squibb position peaked at $2.34M in Q2 2014.
1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.